静脉血栓栓塞-话题@MedSci

#静脉血栓栓塞#

15篇内容 | 3603人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2236500, encodeId=a010223650077, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a>, objectTitle=【今日分享】2024 ESAIC指南：欧洲围手术期静脉血栓栓塞预防指南（第2章：胸部肿瘤外科患者）第一次更新, objectType=article, longId=850946, objectId=fd968509460c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241112/1731388100575_8538692.png, objectUrl=/article/show_article.do?id=fd968509460c, replyNumber=0, likeNumber=5, createdTime=2024-11-12, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fd968509460c, moduleTitle=【今日分享】2024 ESAIC指南：欧洲围手术期静脉血栓栓塞预防指南（第2章：胸部肿瘤外科患者）第一次更新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd968509460c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2228943, encodeId=24ad222894392, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a> <a href='/topic/show?id=aa0611692863' target=_blank style='color:#2F92EE;'>#慢性淋巴细胞白血病（CLL）#</a> <a href='/topic/show?id=62eae8968e3' target=_blank style='color:#2F92EE;'>#继发性恶性肿瘤#</a> <a href='/topic/show?id=bc70119800aa' target=_blank style='color:#2F92EE;'>#单克隆B细胞增多症#</a>, objectTitle=J Thromb Haemost：单克隆 B 细胞淋巴细胞增多症和慢性淋巴细胞白血病患者静脉血栓栓塞的发病率、危险因素和结局, objectType=article, longId=845689, objectId=09d9845689ba, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240718/1721281386020_92910.jpg, objectUrl=/article/show_article.do?id=09d9845689ba, replyNumber=0, likeNumber=117, createdTime=2024-10-02, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=09d9845689ba, moduleTitle=J Thromb Haemost：单克隆 B 细胞淋巴细胞增多症和慢性淋巴细胞白血病患者静脉血栓栓塞的发病率、危险因素和结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=09d9845689ba)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2227218, encodeId=f724222e218dd, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a> <a href='/topic/show?id=594853956a' target=_blank style='color:#2F92EE;'>#ctDNA#</a>, objectTitle=IVD前沿丨ctDNA用来预测癌症相关的静脉血栓栓塞, objectType=article, longId=844155, objectId=d1bf844155f8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240920/1726828988707_8538692.jpg, objectUrl=/article/show_article.do?id=d1bf844155f8, replyNumber=0, likeNumber=72, createdTime=2024-09-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d1bf844155f8, moduleTitle=IVD前沿丨ctDNA用来预测癌症相关的静脉血栓栓塞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1bf844155f8)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2224767, encodeId=862a2224e67b3, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a>, objectTitle=Immunity：抗体和补体是血栓形成的关键驱动因素, objectType=article, longId=842450, objectId=78b3842450a2, topicUrl=null, isHasObj=0, objectCover=https://msimg.bioon.com/bioon-com/20240905/decfc3215e8243e3ab65da8e5cf940b5-3ZEYNvT2o5xR.jpg, objectUrl=/article/show_article.do?id=78b3842450a2, replyNumber=0, likeNumber=15, createdTime=2024-09-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2223523, encodeId=e4dc22235235b, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a> <a href='/topic/show?id=62028230e83' target=_blank style='color:#2F92EE;'>#肺血栓#</a> <a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a>, objectTitle=Transfusion：输血反应与输血患者血栓形成的相关性——回顾性队列研究, objectType=article, longId=840807, objectId=222f84080e48, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240826/1724638905319_8538692.png, objectUrl=/article/show_article.do?id=222f84080e48, replyNumber=0, likeNumber=119, createdTime=2024-09-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=222f84080e48, moduleTitle=Transfusion：输血反应与输血患者血栓形成的相关性——回顾性队列研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=222f84080e48)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2221484, encodeId=18962221484a2, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a> <a href='/topic/show?id=d9152651432' target=_blank style='color:#2F92EE;'>#体力活动#</a> <a href='/topic/show?id=7467951e7b1' target=_blank style='color:#2F92EE;'>#遗传易感性#</a>, objectTitle=Eur J Prev Cardiol：体力活动、遗传易感性与静脉血栓栓塞风险的关系, objectType=article, longId=839766, objectId=4300839e666e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240820/1724122424686_92910.png, objectUrl=/article/show_article.do?id=4300839e666e, replyNumber=0, likeNumber=198, createdTime=2024-08-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4300839e666e, moduleTitle=Eur J Prev Cardiol：体力活动、遗传易感性与静脉血栓栓塞风险的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4300839e666e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2216855, encodeId=f016221685550, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a> <a href='/topic/show?id=3ce252932f0' target=_blank style='color:#2F92EE;'>#恶性肿瘤#</a>, objectTitle=肿瘤患者第二大死因，静脉血栓栓塞风险如何评估？, objectType=article, longId=836178, objectId=47f48361e83c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240725/1721902488170_8538692.jpg, objectUrl=/article/show_article.do?id=47f48361e83c, replyNumber=0, likeNumber=89, createdTime=2024-07-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=47f48361e83c, moduleTitle=肿瘤患者第二大死因，静脉血栓栓塞风险如何评估？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47f48361e83c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2210163, encodeId=f65422101633a, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a>, objectTitle=J Thromb Haemost：用于评估未诱发静脉血栓栓塞患者出血风险的工具：PLATO-VTE研究的分析, objectType=article, longId=830017, objectId=7ae983001e42, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240611/1718092706726_5579292.jpg, objectUrl=/article/show_article.do?id=7ae983001e42, replyNumber=0, likeNumber=103, createdTime=2024-06-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7ae983001e42, moduleTitle=J Thromb Haemost：用于评估未诱发静脉血栓栓塞患者出血风险的工具：PLATO-VTE研究的分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ae983001e42)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2210188, encodeId=68282210188d4, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a> <a href='/topic/show?id=8fd798194dd' target=_blank style='color:#2F92EE;'>#降脂治疗#</a>, objectTitle=Eur Heart J：降脂治疗预防静脉血栓栓塞的效果, objectType=article, longId=830312, objectId=689a830312ae, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240615/1718438203282_5579292.jpg, objectUrl=/article/show_article.do?id=689a830312ae, replyNumber=0, likeNumber=109, createdTime=2024-06-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=689a830312ae, moduleTitle=Eur Heart J：降脂治疗预防静脉血栓栓塞的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=689a830312ae)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2201587, encodeId=e69e220158e7e, content=<a href='/topic/show?id=970e659640a' target=_blank style='color:#2F92EE;'>#淋巴瘤#</a> <a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a>, objectTitle=【AJH】淋巴瘤的VTE风险预测模型, objectType=article, longId=823997, objectId=6b8a82399ec8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/busy-reception-in-a-hospital-with-doctors-and-PUPDEB8.jpg, objectUrl=/article/show_article.do?id=6b8a82399ec8, replyNumber=0, likeNumber=134, createdTime=2024-05-03, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6b8a82399ec8, moduleTitle=【AJH】淋巴瘤的VTE风险预测模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b8a82399ec8)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2188880, encodeId=940b218888072, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a> <a href='/topic/show?id=be8384e20c0' target=_blank style='color:#2F92EE;'>#脑出血患者#</a>, objectTitle=神经外科ICU脑出血患者静脉血栓栓塞预防与管理的证据总结, objectType=article, longId=814463, objectId=17c6814463a6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668016400776_4754896.jpg, objectUrl=/article/show_article.do?id=17c6814463a6, replyNumber=0, likeNumber=110, createdTime=2024-02-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=17c6814463a6, moduleTitle=神经外科ICU脑出血患者静脉血栓栓塞预防与管理的证据总结, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17c6814463a6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2185774, encodeId=83632185e74c0, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a> <a href='/topic/show?id=52941002359d' target=_blank style='color:#2F92EE;'>#预测模型#</a>, objectTitle=静脉血栓栓塞症抗凝治疗相关出血风险预测模型研究进展, objectType=article, longId=812219, objectId=7235812219b3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240131/523e4858a56d4fec85b15a292a00b385.jpg, objectUrl=/article/show_article.do?id=7235812219b3, replyNumber=0, likeNumber=153, createdTime=2024-02-04, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=加利福尼亚, moduleDTOList=[ModuleDTO(moduleId=7235812219b3, moduleTitle=静脉血栓栓塞症抗凝治疗相关出血风险预测模型研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7235812219b3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2174512, encodeId=493e21e451250, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a> 静脉血栓栓塞（VTE）是一种常见的心血管疾病，其发病率逐年增加。肥胖被确认为VTE的危险因素，而全球范围内肥胖的流行率也在快速上升。肥胖定义为体质指数（BMI）达到30 kg/m2或更高。过去的研究已经揭示肥胖与VTE之间的紧密关系，但在肥胖患者中使用直接口服抗凝药（DOACs）的安全性和有效性方面的证据相对有限。, objectTitle=静脉血栓栓塞, objectType=topic, longId=99179, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=61, createdTime=2023-12-12, rootId=0, userName=yangchou, userId=88b489038, projectId=1, avatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, status=1, hasArticle=0, attachment=null, ipAttribution=浙江省, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=2174211, encodeId=f6b721e4211ee, content=<a href='/topic/show?id=886438210fb' target=_blank style='color:#2F92EE;'>#口服抗凝剂#</a> <a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a>, objectTitle=Thromb Res:直接作用口服抗凝剂推荐剂量对肥胖与正常体重静脉血栓栓塞患者的现实生活结果, objectType=article, longId=804549, objectId=0fe08045491c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668024236648_4754896.jpeg, objectUrl=/article/show_article.do?id=0fe08045491c, replyNumber=0, likeNumber=124, createdTime=2023-12-11, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0fe08045491c, moduleTitle=Thromb Res:直接作用口服抗凝剂推荐剂量对肥胖与正常体重静脉血栓栓塞患者的现实生活结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fe08045491c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2166109, encodeId=27ab216610922, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a> , objectTitle=成人烧伤患者静脉血栓栓塞症预防的证据总结, objectType=guider, longId=25178, objectId=8ea5d1c00325395d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=8ea5d1c00325395d, replyNumber=0, likeNumber=171, createdTime=2023-11-01, rootId=0, userName=litao2022, userId=1ff65466529, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8ea5d1c00325395d, moduleTitle=成人烧伤患者静脉血栓栓塞症预防的证据总结, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=8ea5d1c00325395d)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2118411, encodeId=e37b211841162, content=<a href='/topic/show?id=3522389386f' target=_blank style='color:#2F92EE;'>#同型半胱氨酸#</a>与<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a>相关, objectTitle=ATVB：同型半胱氨酸与静脉血栓栓塞相关, objectType=article, longId=212214, objectId=62b521221494, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202162/1622647569826_1739456.png, objectUrl=/article/show_article.do?id=62b521221494, replyNumber=0, likeNumber=202, createdTime=2023-03-09, rootId=0, userName=showtest, userId=8f0715, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=62b521221494, moduleTitle=ATVB：同型半胱氨酸与静脉血栓栓塞相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62b521221494)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2116674, encodeId=7f0521166e4bf, content=<a href='/topic/show?id=69bbe11620e' target=_blank style='color:#2F92EE;'>#痛风#</a>发作的<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a>的风险, objectTitle=A&R：伴有痛风发作的静脉血栓栓塞的风险, objectType=article, longId=760501, objectId=dc2be60501e4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230223/1677083414906_5610093.png, objectUrl=/article/show_article.do?id=dc2be60501e4, replyNumber=0, likeNumber=172, createdTime=2023-02-27, rootId=0, userName=showtest, userId=8f0715, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=dc2be60501e4, moduleTitle=A&R：伴有痛风发作的静脉血栓栓塞的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc2be60501e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241573, encodeId=965712415e3e3, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a>与<a href='/topic/show?id=546555239e8' target=_blank style='color:#2F92EE;'>#抗凝药物#</a>, objectTitle=抗凝药物治疗静脉血栓栓塞症争议与共识, objectType=guider, longId=15926, objectId=cb73f1c002328e6f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=cb73f1c002328e6f, replyNumber=0, likeNumber=176, createdTime=2022-08-28, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb73f1c002328e6f, moduleTitle=抗凝药物治疗静脉血栓栓塞症争议与共识, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=cb73f1c002328e6f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241572, encodeId=093a12415e2e2, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a><a href='/topic/show?id=64cf9011550' target=_blank style='color:#2F92EE;'>#补体#</a>, objectTitle=ATVB：补体激活酶MASP-2水平与静脉血栓栓塞的风险相关, objectType=article, longId=733311, objectId=d355e3331156, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220726/1658819607463_1739456.jpg, objectUrl=/article/show_article.do?id=d355e3331156, replyNumber=0, likeNumber=200, createdTime=2022-08-28, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d355e3331156, moduleTitle=ATVB：补体激活酶MASP-2水平与静脉血栓栓塞的风险相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d355e3331156)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241718, encodeId=2c181241e18b8, content=<a href='/topic/show?id=f5f610462e09' target=_blank style='color:#2F92EE;'>#Milvexian#</a>预防<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a>，这是一种新型的<a href='/topic/show?id=8516552389b' target=_blank style='color:#2F92EE;'>#抗凝药#</a>物，未来前景可期！, objectTitle=NEJM：Milvexian用于预防静脉血栓栓塞, objectType=article, longId=221432, objectId=30622214323d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021122/1638403448315_1739456.jpg, objectUrl=/article/show_article.do?id=30622214323d, replyNumber=0, likeNumber=159, createdTime=2022-08-29, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30622214323d, moduleTitle=NEJM：Milvexian用于预防静脉血栓栓塞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30622214323d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

静脉血栓栓塞

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#静脉血栓栓塞#

【今日分享】2024 ESAIC指南：欧洲围手术期静脉血栓栓塞预防指南（第2章：胸部肿瘤外科患者）第一次更新

2024-11-12发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#静脉血栓栓塞# #慢性淋巴细胞白血病（CLL）# #继发性恶性肿瘤# #单克隆B细胞增多症#

J Thromb Haemost：单克隆 B 细胞淋巴细胞增多症和慢性淋巴细胞白血病患者静脉血栓栓塞的发病率、危险因素和结局

2024-10-02发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#静脉血栓栓塞# #ctDNA#

IVD前沿丨ctDNA用来预测癌症相关的静脉血栓栓塞

2024-09-23发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#静脉血栓栓塞#

2024-09-09发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#输血# #肺血栓# #静脉血栓栓塞#

Transfusion：输血反应与输血患者血栓形成的相关性——回顾性队列研究

2024-09-01发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#静脉血栓栓塞# #体力活动# #遗传易感性#

Eur J Prev Cardiol：体力活动、遗传易感性与静脉血栓栓塞风险的关系

2024-08-20发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#静脉血栓栓塞# #恶性肿瘤#

肿瘤患者第二大死因，静脉血栓栓塞风险如何评估？

2024-07-25发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#静脉血栓栓塞#

J Thromb Haemost：用于评估未诱发静脉血栓栓塞患者出血风险的工具：PLATO-VTE研究的分析

2024-06-16发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#静脉血栓栓塞# #降脂治疗#

Eur Heart J：降脂治疗预防静脉血栓栓塞的效果

2024-06-16发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#淋巴瘤# #静脉血栓栓塞#

【AJH】淋巴瘤的VTE风险预测模型

2024-05-03发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#静脉血栓栓塞# #脑出血患者#

神经外科ICU脑出血患者静脉血栓栓塞预防与管理的证据总结

2024-02-23发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#静脉血栓栓塞# #预测模型#

静脉血栓栓塞症抗凝治疗相关出血风险预测模型研究进展

2024-02-04发表于加利福尼亚

yangchou (审核中...)

前往app查看评论内容

全文收起 #静脉血栓栓塞# 静脉血栓栓塞（VTE）是一种常见的心血管疾病，其发病率逐年增加。肥胖被确认为VTE的危险因素，而全球范围内肥胖的流行率也在快速上升。肥胖定义为体质指数（BMI）达到30 kg/m2或更高。过去的研究已经揭示肥胖与VTE之间的紧密关系，但在肥胖患者中使用直接口服抗凝药（DOACs）的安全性和有效性方面的证据相对有限。

2023-12-12发表于浙江省

梅斯管理员 (审核中...)

前往app查看评论内容

#口服抗凝剂# #静脉血栓栓塞#

Thromb Res:直接作用口服抗凝剂推荐剂量对肥胖与正常体重静脉血栓栓塞患者的现实生活结果

2023-12-11发表于上海

(审核中...)

前往app查看评论内容

#静脉血栓栓塞#

成人烧伤患者静脉血栓栓塞症预防的证据总结

2023-11-01发表于上海

showtest (审核中...)

前往app查看评论内容

#同型半胱氨酸#与#静脉血栓栓塞#相关

ATVB：同型半胱氨酸与静脉血栓栓塞相关

2023-03-09发表于上海

showtest (审核中...)

前往app查看评论内容

#痛风#发作的#静脉血栓栓塞#的风险

A&R：伴有痛风发作的静脉血栓栓塞的风险

2023-02-27发表于上海

循证小兵 (审核中...)

前往app查看评论内容

#静脉血栓栓塞#与#抗凝药物#

抗凝药物治疗静脉血栓栓塞症争议与共识

2022-08-28

循证小兵 (审核中...)

前往app查看评论内容

#静脉血栓栓塞##补体#

ATVB：补体激活酶MASP-2水平与静脉血栓栓塞的风险相关

2022-08-28

循证小兵 (审核中...)

前往app查看评论内容

#Milvexian#预防#静脉血栓栓塞#，这是一种新型的#抗凝药#物，未来前景可期！

NEJM：Milvexian用于预防静脉血栓栓塞

2022-08-29

科室
- - 订阅+
  - 更多科室
工具
服务